Literature DB >> 7740544

Evaluation of the neurotoxicity of glycidamide, an epoxide metabolite of acrylamide: behavioral, neurochemical and morphological studies.

L G Costa1, H Deng, C J Calleman, E Bergmark.   

Abstract

Acrylamide is an important chemical used in the synthesis of polyacrylamides, which have a wide variety of industrial applications. The principal toxic effect of acrylamide, both in animals and in humans, is neurotoxicity. Peripheral nervous system effects are most prominent, but central nervous system effects have also been reported. Acrylamide is metabolized to the epoxide glycidamide, whose adducts to hemoglobin and to DNA have been identified in animals and humans. This metabolite may be involved in the reproductive and carcinogenic effects of acrylamide. In the present study we investigated whether glycidamide would exert neurotoxic effects similar to those caused by its parent compound. Male rats were injected i.p. with acrylamide (25 or 50 mg/kg) or glycidamide (50 or 100 mg/kg) daily for 8 days. Reduced weight gain was evident in animals exposed to glycidamide or to the higher dose of acrylamide. Both compounds induced lethargy and ataxia, but the posture of glycidamide-treated rats differed from that of animals treated with acrylamide. At the high doses, both compounds significantly affected rats' behavior in the rotarod test; on the other hand, only acrylamide was effective in the hindlimb splay test. Acrylamide inhibited activity of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in sciatic and tibial nerves, as well as in brain. Glycidamide inhibited GAPDH activity only in brain and activity of creatine kinase in both peripheral and central tissues. Acrylamide also caused profound urinary retention and distended bladders, while the effects of glycidamide were minimal. Morphological abnormalities were seen in sciatic nerves and dorsal root ganglion cells of rats treated with acrylamide (50 mg/kg x 12), but not in rats exposed to glycidamide (100 mg/kg x 11). These results indicate that the toxicities of acrylamide and glycidamide differ and suggest that acrylamide itself may be primarily responsible for its peripheral neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7740544     DOI: 10.1016/0300-483x(94)02986-5

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  5 in total

1.  Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimens.

Authors:  Stephanie J Wallace; Jian Li; Roger L Nation; Craig R Rayner; David Taylor; Deborah Middleton; Robert W Milne; Kingsley Coulthard; John D Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2008-01-07       Impact factor: 5.191

Review 2.  Biomarker research in neurotoxicology: the role of mechanistic studies to bridge the gap between the laboratory and epidemiological investigations.

Authors:  L G Costa
Journal:  Environ Health Perspect       Date:  1996-03       Impact factor: 9.031

3.  Acrylamide inhibits nerve sprouting induced by botulinum toxin type A.

Authors:  Hong Jiang; Yi Xiang; Xingyue Hu; Huaying Cai
Journal:  Neural Regen Res       Date:  2014-08-15       Impact factor: 5.135

4.  Beyond detoxification: Pleiotropic functions of multiple glutathione S-transferase isoforms protect mice against a toxic electrophile.

Authors:  Kelsey A Behrens; Leigh A Jania; John N Snouwaert; MyTrang Nguyen; Sheryl S Moy; Andrey P Tikunov; Jeffrey M Macdonald; Beverly H Koller
Journal:  PLoS One       Date:  2019-11-20       Impact factor: 3.240

5.  Taurine attenuates acrylamide-induced axonal and myelinated damage through the Akt/GSK3β-dependent pathway.

Authors:  Guohua Sun; Shuxian Qu; Siyi Wang; Ying Shao; Jingsong Sun
Journal:  Int J Immunopathol Pharmacol       Date:  2018 Jan-Dec       Impact factor: 3.219

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.